查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726194

計算病理學市場規模、佔有率、趨勢分析報告：按組件、應用、技術、最終用途、地區和細分市場預測，2025 年至 2030 年

Computational Pathology Market Size, Share & Trends Analysis Report By Component By Application, By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

計算病理學市場的成長和趨勢

根據Grand View Research, Inc.的最新報告，全球計算病理學市場規模預計到2030年將達到10.4億美元，2025年至2030年期間的複合年成長率為8.24%。

這種成長歸因於慢性病患病率的上升、對快速診斷的先進解決方案的需求的增加、機器學習 (ML) 和人工智慧 (AI) 技術的日益融合，以及專注於開發先進解決方案的市場參與者對醫療保健的投資不斷增加。

將人工智慧 (AI) 和機器學習 (ML) 演算法整合到數位病理工作流程中，可以快速且準確地分析病理影像，從而徹底改變這一領域。人工智慧工具可以幫助病理學家檢測模式、預測疾病進展並提供對疾病檢測至關重要的臨床相關見解。例如，2024 年 9 月，Page 推出了 Page 阿魯巴 ，這是一款臨床多模態、多模式副駕駛，旨在改變個人化醫療和精準腫瘤學。 Alba 從患者數據中提供即時、人工智慧主導的洞察，以前所未有的速度和規模增強臨床決策。這項創新標誌著醫療保健領域向通用人工智慧 (AGI) 邁出了一大步，使該行業更接近未來，即人工智慧不僅支持臨床醫生，而且還與臨床醫生合作診斷和治療癌症等複雜疾病。

在這個市場營運的幾家公司也專注於開發創新解決方案，以推進計算病理學的應用和性能。例如，2023年8月，微軟與佩奇研發中心合作開發了第二代計算病理學基礎模型Virchow2和Virchow2G。這些大規模語言模型在大量病理資料上進行訓練，以了解臨床資訊、病理學觀察和疾病結果之間的複雜關係。

Virchow2 和 Virchow2G 可以產生人類可讀的文本來回答問題並協助完成報告撰寫和案例摘要等任務。這些模型旨在針對特定任務進行微調，並可用於各種計算病理學應用。這項進步代表著利用人工智慧增強病理學家的決策能力和改善計算病理學中的患者照護邁出了重要一步。同樣，從傳統顯微鏡到數位病理學的轉變也進一步促進了市場的成長。這一轉變將提高可及性並促進世界各地病理學家的遠端諮詢和協作。

隨著衛生系統尋求其他開展業務的方式，同時確保遵守安全通訊協定，COVID-19 疫情加速了這一趨勢。此外，監管機構對數位病理學的發展做出了重大貢獻，促成了各種數位成像系統和軟體應用程式的核准。隨著組織投資基礎設施以支援數位化工作流程，市場預計將在業務效率提高和診斷能力增強的基礎上實現顯著成長。

計算病理學市場報告重點

  • 從組件來看，軟體領域在 2024 年佔據了市場主導地位，這要歸功於這些解決方案提供的各種優勢，有助於增強臨床工作流程。
  • 從應用角度來看，由於全球醫院和診斷中心對更有效、更準確的診斷工具的需求不斷增加，疾病診斷將在應用領域佔據主導地位，到 2024 年其收入佔有率將達到 45.7%。
  • 從技術角度來看，機器學習在 2024 年佔據了市場主導地位。這是因為正在開發的計算病理學解決方案越來越多，這些解決方案整合了機器學習技術，以便在醫療機構中提供更好的性能和結果。
  • 按最終用途分類，醫院和診斷實驗室部門在 2024 年佔據最大的市場佔有率，為 51.09%。
  • 2024 年，北美佔據了最大的市場佔有率，為 40.5%。這是由於該地區的醫療保健基礎設施正在發展，加上癌症等慢性病發病率上升，以及獲得計算病理學解決方案的機會不斷增加。
  • 主要企業正在採用各種策略，例如產品發布、合作、收購和合併，以擴大其服務組合併加強其地理影響力，從而導致市場競爭激烈。例如，2023年2月，ClaraPass收購了Crossscope，旨在透過整合組織處理機器人和人工智慧數位病理學來實現「未來實驗室」。這種組合透過自動化組織處理提高了工作流程效率，同時利用人工智慧技術進行進階影像分析和診斷。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章計算病理學市場變數、趨勢和範圍

  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
  • 計算病理學市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析
    • 新興科技趨勢
    • COVID-19影響分析
    • 使用案例分析

第4章計算病理學市場：各組成部分的估計和趨勢分析

  • 2024年及2030年零件市場佔有率
  • 細分儀表板
  • 全球計算病理學市場展望（按組成部分）
  • 軟體
  • 服務

第5章 計算病理學市場：應用、評估與趨勢分析

  • 2024年及2030年的應用市場佔有率
  • 細分儀表板
  • 全球計算病理學市場應用展望
  • 疾病診斷
  • 藥物研發
  • 學術研究

第6章計算病理學市場：技術評估與趨勢分析

  • 2024 年及 2030 年技術市場佔有率
  • 細分儀表板
  • 全球計算病理學市場技術展望
  • 機器學習（ML）
    • 深度學習
    • 其他
  • 自然語言處理 (NLP) 模型
  • 電腦視覺
  • 其他

第7章計算病理學市場：按最終用途的估計和趨勢分析

  • 2024 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 全球計算病理學市場展望（按最終用途）
  • 醫院和診斷實驗室
  • 生物技術和製藥公司
  • 學術研究所
  • 其他

第 8 章計算病理學市場：區域估計和趨勢分析、按組件、按應用、按技術、按最終用途

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 2024年主要企業的市場佔有率/地位分析
  • 公司簡介
    • Leica Biosystems Nussloch GmbH（Danaher）
    • Hamamatsu Photonics KK
    • Koninklijke Philips NV
    • Olympus Corporation
    • F. Hoffmann-La Roche Ltd.
    • Mikroscan Technologies, Inc.
    • Epredia（3DHISTECH Ltd.）
    • Visiopharm A/S
    • Proscia Inc.
    • Tempus
    • Huron Technologies International Inc.
    • ContextVision AB
    • CellaVision
    • aetherAI
    • CellCarta
    • IBEX（IBEX MEDICAL ANALYTICS）
    • Nucleai, Inc.
Product Code: GVR-4-68040-548-5

Computational Pathology Market Growth & Trends:

The global computational pathology market size is expected to reach USD 1.04 billion by 2030, registering a CAGR of 8.24% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising prevalence of chronic diseases, the increasing demand for advanced solutions for faster diagnosis, the rising integration of Machine Learning (ML) and artificial intelligence (AI) technologies and increasing investment in healthcare supported by market players focused on developing advanced solutions.

Integrating artificial intelligence (AI) and machine learning (ML) algorithms into digital pathology workflows is revolutionizing the field, enabling faster and more accurate analysis of pathology images. AI-powered tools can assist pathologists in detecting patterns, predicting disease progression, and giving clinically relevant insights crucial for disease detection. For instance, In September 2024, Paige introduced Paige Alba, a clinical-grade multimodal co-pilot aimed at transforming personalized medicine and precision oncology. Alba provides real-time, AI-driven insights from patient data, enhancing clinical decision-making at unprecedented speed and scale. This innovation represents a major leap toward Artificial General Intelligence (AGI) in healthcare, bringing the industry closer to a future where AI not only supports but collaborates with clinicians in diagnosing and treating complex diseases such as cancer.

Several companies operating in the market also focusing on developing innovative solutions to enhance the application and performance of computational pathology. For instance, in August 2023, Microsoft and Paige researchers developed Virchow2 and Virchow2G, second-generation foundation models for computational pathology. These large language models are trained on vast amounts of pathology data to understand the complex relationships between clinical information, pathology findings, and disease outcomes.

Virchow2 and Virchow2G can generate human-readable text, answer questions, and assist in tasks like report generation and case summarization. The models are designed to be fine-tuned for specific tasks, enabling their use in various computational pathology applications. This advancement represents a significant step forward in leveraging AI to enhance pathologists' decision-making and improve patient care in computational pathology. Similarly, transitioning from traditional microscopy to digital pathology further contributes to the market growth. This shift enhances accessibility and facilitates remote consultations and collaborative efforts among pathologists worldwide.

The COVID-19 pandemic has accelerated this trend as healthcare systems search for alternatives to execute operations while ensuring compliance with safety protocols. Furthermore, regulatory bodies significantly contribute to digital pathology's growth, leading to approvals for various digital imaging systems and software applications. As organizations invest in infrastructure to support digital workflows, the market is expected to witness significant growth driven by enhanced operational efficiencies and improved diagnostic capabilities.

Computational Pathology Market Report Highlights:

  • Based on component, software segment dominated the market in 2024 owing to the various advantages offered by these solutions that help in enhancing clinical workflows.
  • Based on application, disease diagnosis dominated the application segment with a revenue share of 45.7% in 2024 owing to the rising demand for more effective and accurate diagnosis tools in hospitals and diagnostics centers globally.
  • Based on technology, machine learning dominated the market in 2024 owing to the rising development of computational pathology solutions with integrated ML technologies that offer better performance and outcomes in healthcare facilities.
  • Based on end use, hospitals and diagnostic labs segment held the largest market share of 51.09% in 2024, driven by the increasing demand for advanced diagnostic tools and efficient workflow solutions.
  • North America held the largest market share of 40.5% in 2024. This can be attributed to the regions developed healthcare infrastructure and increasing access to the computational pathology solutions coupled with the rising incidents of the chronic diseases such as cancer.
  • Major players are employing various strategies such as product launches, collaborations, acquisitions, and mergers to expand their service portfolios and enhance their geographical presence, leading to significant competition within the market. For instance, in February 2023, ClaraPath acquired Crosscope to integrate tissue processing robotics with AI-powered digital pathology, aiming to create the "lab of the future." This combination enhances workflow efficiency by automating tissue processing while leveraging AI technologies for advanced image analysis and diagnostics.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional scope
    • 1.1.2. Component
    • 1.1.3. Technology
    • 1.1.4. Application
    • 1.1.5. End Use
    • 1.1.6. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Component
    • 2.2.2. Technology
    • 2.2.3. Application
    • 2.2.4. End Use
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Computational Pathology Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
    • 3.1.2. Market restraint analysis
    • 3.1.3. Market Opportunity Analysis
  • 3.2. Computational Pathology Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape
    • 3.2.3. Emerging Technology Trends
    • 3.2.4. COVID-19 Impact Analysis
    • 3.2.5. Case Study Analysis

Chapter 4. Computational Pathology Market: Component Estimates & Trend Analysis

  • 4.1. Component Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Computational Pathology Market by Component Outlook
  • 4.4. Software
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Computational Pathology Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Computational Pathology Market by Application Outlook
  • 5.4. Disease Diagnosis
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Drug Discovery & Development
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Academic Research
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Computational Pathology Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Computational Pathology Market by Technology Outlook
  • 6.4. Machine Learning (ML)
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.2. Deep Learning
      • 6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.3. Others
      • 6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Natural Language Processing (NLP) Models
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Computer Vision
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Computational Pathology Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Market Share, 2024 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Computational Pathology Market by End Use Outlook
  • 7.4. Hospitals and Diagnostic Labs
    • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5. Biotechnology and Pharmaceutical Companies
    • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.6. Academic and Research Institutes
    • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Computational Pathology Market: Regional Estimates & Trend Analysis, By Component, By Application, By Technology, By End Use

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Key company market share/position analysis, 2024
  • 9.4. Company Profiles
    • 9.4.1. Leica Biosystems Nussloch GmbH (Danaher)
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Hamamatsu Photonics K.K.
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Koninklijke Philips N.V.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Olympus Corporation
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. F. Hoffmann-La Roche Ltd.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Mikroscan Technologies, Inc.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Epredia (3DHISTECH Ltd.)
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Visiopharm A/S
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Proscia Inc.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Tempus
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Huron Technologies International Inc.
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. ContextVision AB
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. CellaVision
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. aetherAI
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives
    • 9.4.15. CellCarta
      • 9.4.15.1. Company overview
      • 9.4.15.2. Financial performance
      • 9.4.15.3. Product benchmarking
      • 9.4.15.4. Strategic initiatives
    • 9.4.16. IBEX (IBEX MEDICAL ANALYTICS)
      • 9.4.16.1. Company overview
      • 9.4.16.2. Financial performance
      • 9.4.16.3. Product benchmarking
      • 9.4.16.4. Strategic initiatives
    • 9.4.17. Nucleai, Inc.
      • 9.4.17.1. Company overview
      • 9.4.17.2. Financial performance
      • 9.4.17.3. Product benchmarking
      • 9.4.17.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Computational Pathology Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 4 North America Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 5 North America Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 6 North America Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 7 U.S. Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 8 U.S. Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 9 U.S. Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 10 U.S. Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 11 Canada Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 12 Canada Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 13 Canada Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 14 Canada Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 15 Mexico Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 16 Mexico Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 17 Mexico Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 18 Mexico Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 19 Europe Computational Pathology Market, By Region, 2018 - 2030 (USD Million)
  • Table 20 Europe Computational Pathology Market, By Component, 2018 - 2030 (USD Million)
  • Table 21 Europe Computational Pathology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 22 Europe Computational Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 Europe Computational Pathology Market, By End use, 2018 - 2030 (USD Million)
  • Table 24 Germany Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 25 Germany Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 26 Germany Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 27 Germany Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 28 UK Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 29 UK Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 30 UK Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 31 UK Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 32 France Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 33 France Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 34 France Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 35 France Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 36 Italy Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 37 Italy Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 38 Italy Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 39 Italy Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 40 Spain Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 41 Spain Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 42 Spain Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 43 Spain Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 44 Denmark Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 45 Denmark Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 46 Denmark Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 47 Denmark Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 48 Sweden Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 49 Sweden Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 50 Sweden Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 51 Sweden Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 52 Norway Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 53 Norway Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 54 Norway Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 55 Norway Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Computational Pathology Market, by region, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 61 China Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 62 China Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 63 China Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 64 China Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 65 Japan Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 66 Japan Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 67 Japan Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 68 Japan Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 69 India Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 70 India Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 71 India Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 72 India Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 73 South Korea Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 74 South Korea Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 75 South Korea Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 76 South Korea Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 77 Australia Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 78 Australia Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 79 Australia Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 80 Australia Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 81 Thailand Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 82 Thailand Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 83 Thailand Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 84 Thailand Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 85 Latin America Computational Pathology Market, by region, 2018 - 2030 (USD Million)
  • Table 86 Latin America Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 87 Latin America Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 88 Latin America Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 89 Latin America Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 90 Brazil Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 91 Brazil Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 92 Brazil Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 93 Brazil Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 94 Argentina Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 95 Argentina Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 96 Argentina Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 97 Argentina Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 98 MEA Computational Pathology Market, by region, 2018 - 2030 (USD Million)
  • Table 99 MEA Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 100 MEA Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 101 MEA Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 102 MEA Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 103 South Africa Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 104 South Africa Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 105 South Africa Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 106 South Africa Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 111 UAE Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 112 UAE Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 113 UAE Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 114 UAE Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait Computational Pathology Market, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 119 Kuwait Computational Pathology Market By End use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Computational Pathology Market outlook
  • Fig. 9 Computational Pathology competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Computational Pathology Market driver impact
  • Fig. 15 Computational Pathology Market restraint impact
  • Fig. 16 Computational Pathology Market strategic initiatives analysis
  • Fig. 17 Computational Pathology Market: Component movement analysis
  • Fig. 18 Computational Pathology Market: Component outlook and key takeaways
  • Fig. 19 Software market estimates and forecast, 2018 - 2030
  • Fig. 20 Services market estimates and forecast, 2018 - 2030
  • Fig. 21 Computational Pathology Market: Application movement analysis
  • Fig. 22 Computational Pathology Market: Application outlook and key takeaways
  • Fig. 23 Disease diagnosis market estimates and forecast, 2018 - 2030
  • Fig. 24 Drug discovery & development market estimates and forecast, 2018 - 2030
  • Fig. 25 Academic research market estimates and forecast, 2018 - 2030
  • Fig. 26 Computational Pathology Market: Technology movement analysis
  • Fig. 27 Computational Pathology Market: Technology outlook and key takeaways
  • Fig. 28 Machine Learning (ML) market estimates and forecast, 2018 - 2030
  • Fig. 29 Deep Learning market estimates and forecast, 2018 - 2030
  • Fig. 30 Others market estimates and forecast, 2018 - 2030
  • Fig. 31 Natural Language Processing (NLP) models market estimates and forecast, 2018 - 2030
  • Fig. 32 Computer vision market estimates and forecast, 2018 - 2030
  • Fig. 33 Others market estimates and forecast, 2018 - 2030
  • Fig. 34 Computational Pathology Market: End use movement analysis
  • Fig. 35 Computational Pathology Market: End use outlook and key takeaways
  • Fig. 36 Hospitals and Diagnostic Labs market estimates and forecast, 2018 - 2030
  • Fig. 37 Biotechnology and Pharmaceutical Companies market estimates and forecast, 2018 - 2030
  • Fig. 38 Academic and Research Institutes market estimates and forecast, 2018 - 2030
  • Fig. 39 Other market estimates and forecast, 2018 - 2030
  • Fig. 40 Global Computational Pathology Market: Regional movement analysis
  • Fig. 41 Global Computational Pathology Market: Regional outlook and key takeaways
  • Fig. 42 Global Computational Pathology Market share and leading players
  • Fig. 43 North America market share and leading players
  • Fig. 44 Europe market share and leading players
  • Fig. 45 Asia Pacific market share and leading players
  • Fig. 46 Latin America market share and leading players
  • Fig. 47 Middle East & Africa market share and leading players
  • Fig. 48 North America market estimates and forecasts, 2018 - 2030
  • Fig. 49 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 50 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 51 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 52 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 53 UK market estimates and forecasts, 2018 - 2030
  • Fig. 54 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 55 France market estimates and forecasts, 2018 - 2030
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 57 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 58 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 59 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 60 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 62 China market estimates and forecasts, 2018 - 2030
  • Fig. 63 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 64 India market estimates and forecasts, 2018 - 2030
  • Fig. 65 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 66 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 67 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 68 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 69 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 70 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 71 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 72 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 73 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 74 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 75 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 76 Market share of key market players- Computational Pathology Market
  • Fig. 77 Key Company Categorization
  • Fig. 78 Company Market Share/Position Analysis, 2024
  • Fig. 79 Strategic Framework